CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the...
82
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 125387Orig1s000 PHARMACOLOGY REVIEW(S)
Transcript of CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the...
![Page 1: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/1.jpg)
CENTER FOR DRUG EVALUATION AND RESEARCH
APPLICATION NUMBER:
125387Orig1s000
PHARMACOLOGY REVIEW(S)
![Page 2: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/2.jpg)
![Page 3: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/3.jpg)
![Page 4: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/4.jpg)
![Page 5: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/5.jpg)
![Page 6: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/6.jpg)
![Page 7: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/7.jpg)
![Page 8: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/8.jpg)
![Page 9: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/9.jpg)
![Page 10: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/10.jpg)
![Page 11: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/11.jpg)
![Page 12: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/12.jpg)
![Page 13: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/13.jpg)
![Page 14: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/14.jpg)
![Page 15: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/15.jpg)
![Page 16: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/16.jpg)
![Page 17: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/17.jpg)
![Page 18: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/18.jpg)
![Page 19: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/19.jpg)
![Page 20: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/20.jpg)
![Page 21: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/21.jpg)
![Page 22: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/22.jpg)
![Page 23: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/23.jpg)
![Page 24: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/24.jpg)
![Page 25: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/25.jpg)
![Page 26: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/26.jpg)
![Page 27: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/27.jpg)
![Page 28: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/28.jpg)
![Page 29: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/29.jpg)
![Page 30: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/30.jpg)
![Page 31: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/31.jpg)
![Page 32: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/32.jpg)
![Page 33: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/33.jpg)
![Page 34: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/34.jpg)
![Page 35: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/35.jpg)
![Page 36: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/36.jpg)
![Page 37: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/37.jpg)
![Page 38: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/38.jpg)
![Page 39: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/39.jpg)
![Page 40: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/40.jpg)
![Page 41: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/41.jpg)
![Page 42: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/42.jpg)
![Page 43: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/43.jpg)
![Page 44: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/44.jpg)
![Page 45: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/45.jpg)
![Page 46: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/46.jpg)
![Page 47: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/47.jpg)
![Page 48: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/48.jpg)
![Page 49: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/49.jpg)
![Page 50: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/50.jpg)
![Page 51: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/51.jpg)
![Page 52: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/52.jpg)
![Page 53: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/53.jpg)
![Page 54: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/54.jpg)
![Page 55: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/55.jpg)
![Page 56: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/56.jpg)
![Page 57: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/57.jpg)
![Page 58: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/58.jpg)
![Page 59: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/59.jpg)
![Page 60: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/60.jpg)
![Page 61: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/61.jpg)
![Page 62: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/62.jpg)
![Page 63: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/63.jpg)
![Page 64: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/64.jpg)
![Page 65: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/65.jpg)
![Page 66: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/66.jpg)
![Page 67: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/67.jpg)
![Page 68: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/68.jpg)
![Page 69: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/69.jpg)
![Page 70: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/70.jpg)
![Page 71: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/71.jpg)
![Page 72: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/72.jpg)
![Page 73: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/73.jpg)
![Page 74: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/74.jpg)
![Page 75: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/75.jpg)
![Page 76: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/76.jpg)
![Page 77: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/77.jpg)
![Page 78: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/78.jpg)
![Page 79: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/79.jpg)
![Page 80: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/80.jpg)
![Page 81: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/81.jpg)
![Page 82: CENTER FOR DRUG EVALUATION AND RESEARCH · Determination of Equilibrium Binding Constants for the Interaction of Human VEGF-A165 and Human PIGF-2 with Aflibercept Conformance and](https://reader030.fdocuments.net/reader030/viewer/2022040112/5e8c3942e00ee75d85307b92/html5/thumbnails/82.jpg)